BioAge Labs (BIOA) Non-Current Debt (2023 - 2025)

BioAge Labs has disclosed Non-Current Debt across 3 years of filings, most recently posting $1.1 million for Q1 2025.

• In Q1 2025, Non-Current Debt changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2025 stood at $1.1 million (changed N/A YoY), while the FY2024 annual figure was $2.5 million, down 69.49% from the prior year.
• Non-Current Debt came in at $1.1 million for Q1 2025 at BioAge Labs, down from $2.5 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $8.2 million in Q4 2023 to a low of $1.1 million in Q1 2025.
• Average Non-Current Debt over 3 years is $3.9 million, with a median of $3.2 million recorded in 2024.
• The largest YoY upside for Non-Current Debt was 69.49% in 2024 against a maximum downside of 69.49% in 2024.
• Over 3 years, Non-Current Debt stood at $8.2 million in 2023, then slumped by 69.49% to $2.5 million in 2024, then sank by 57.79% to $1.1 million in 2025.
• Per Business Quant data, the three most recent Non-Current Debt figures were $1.1 million in Q1 2025, $2.5 million in Q4 2024, and $3.9 million in Q3 2024.